January 10, 2012 -- Norwich Pharmaceuticals today announced that Terence Novak has joined the company as president, Commercial Operations. Novak will provide strategic leadership for Norwich Pharmaceuticals’ commercial business group that includes sales, marketing and customer service. Novak will report to Chief Executive Officer Doug Drysdale.
“We are pleased to welcome Terry Novak to Norwich and look forward to his results-oriented approach to business development and customer service,” stated Drysdale. “His expertise within the contract services industry complemented by his energetic commitment to customers will be a strong addition to our leadership team.”
Novak was most recently president and chief commercial officer for Patheon, Inc., where he successfully achieved an increase in new business while also overseeing five manufacturing facilities. Prior to this role, Novak held several senior leadership positions at DSM Pharmaceuticals including senior vice president commercial operations; executive vice president and chief marketing officer; and president and business unit director. Novak also possesses more than fifteen years sales and management experience with Bristol Myers Squibb. He holds a Bachelor of Science in biology from Muhlenberg College.
About Norwich
Norwich is a full-service contract development and manufacturing provider for Rx and OTC pharmaceuticals. Norwich applies more than 120 years of experience and an unparalleled compliance record to offer customers greater flexibility, resources and speed that result in a streamlined progression from product development to scale-up and commercial manufacturing through clinical services. Visit www.norwichpharma.com for additional information.
